Virginia Administrative Code › Title 18 - PROFESSIONAL AND OCCUPATIONAL LICENSING › Agency 110 - BOARD OF PHARMACY › Chapter 20 - REGULATIONS GOVERNING THE PRACTICE OF PHARMACY › Part I - General Provisions › Section 18VAC110-20-10 - Definitions

Current through Register Vol. 40, No. 24, July 15, 2024
In addition to words and terms defined in §§
										54.1-3300 and
					 54.1-3401
					 of the Code of Virginia, the following words and terms when used in this
					 chapter shall have the following meanings, unless the context clearly indicates
					 otherwise:
"Acquisition" of an existing entity permitted, registered,
					 or licensed by the board means (i) the purchase or transfer of all or
					 substantially all of the assets of the entity or of any corporation that owns
					 or controls the entity; (ii) the creation of a partnership by a sole proprietor
					 or change in partnership composition; (iii) the acquiring of 50% or more of the
					 outstanding shares of voting stock of a corporation owning the entity or of the
					 parent corporation of a wholly owned subsidiary owning the entity, except that
					 this shall not apply to any corporation the voting stock of which is actively
					 traded on any securities exchange or in any over-the-counter market; or (iv)
					 the merger of a corporation owning the entity or of the parent corporation of a
					 wholly owned subsidiary owning the entity with another business or
					 corporation.
"Actively reports" means reporting all dispensing errors
					 and analyses of such errors to a patient safety organization as soon as
					 practical or at least within 30 days of identifying the error.
"Alternate delivery site" means a location authorized in
					 18VAC110-20-275
					 to receive dispensed prescriptions on behalf of and for further delivery or
					 administration to a patient.
"Analysis" means a review of the findings collected and
					 documented on each dispensing error, assessment of the cause and any factors
					 contributing to the dispensing error, and any recommendation for remedial
					 action to improve pharmacy systems and workflow processes to prevent or reduce
					 future errors.
"Authorized collector" means a narcotic treatment program,
					 hospital or clinic with an on-site pharmacy, or pharmacy that is authorized by
					 the U.S. Drug Enforcement Administration to receive drugs for the purpose of
					 destruction.
"Beyond-use date" means the date beyond which the integrity
					 of a compounded, repackaged, or dispensed drug can no longer be assured and as
					 such is deemed to be adulterated or misbranded as defined in §§
										54.1-3461
					 and
					 54.1-3462
					 of the Code of Virginia.
"Board" means the Virginia Board of Pharmacy.
"Chart order" means a lawful order for a drug or device
					 entered on the chart or in a medical record of a patient by a prescriber or the
					 prescriber's designated agent.
"Compliance packaging" means packaging for dispensed drugs
					 that is comprised of a series of containers for solid oral dosage forms and
					 designed to assist the user in administering or self-administering the drugs in
					 accordance with directions for use.
"Correctional facility" means any prison, penitentiary,
					 penal facility, jail, detention unit, or other facility in which persons are
					 incarcerated by government officials.
"DEA" means the U.S. Drug Enforcement
					 Administration.
"Dispensing error" means one or more of the following
					 discovered after the final verification by the pharmacist, regardless of
					 whether the patient received the drug:
1. Variation from the prescriber's
				  prescription drug order, including:
a.
				  Incorrect drug;
b. Incorrect drug
				  strength;
c. Incorrect dosage
				  form;
d. Incorrect patient;
				  or
e. Inadequate or incorrect
				  packaging, labeling, or directions.